2m 2m 2m 2m 2m 2m 2m
INCANNEX HEAL (IXHL)
NASDAQ
$3.07+$0.008 (+0.26%)
Price as of Jun 03, 2026 7:52 PM EDT- $40.1MMarket Cap
- -46.52%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INCANNEX HEAL (IXHL)
$3.07+$0.008 (+0.26%)
IXHL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.06 | ||
Change | -$0.20 (-6.15%) | ||
Open | $3.07 | ||
High | $3.12 | ||
Low | $3.00 | ||
Previous Close | $3.05 | ||
Volume | 175,486 | ||
30-Day Average Volume | 248,098 | ||
1-Week Change | -9.23% | ||
1-Month Change | -32.97% | ||
1-Year Change | -46.52% | ||
3-Year Change | -94.99% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.0M | ||
Total Assets | $80.3M | ||
Market Cap | $40.1M | ||
Enterprise Value | -$34.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.9M | ||
Free Cash Flow | -$2.5M | ||
EBIT | -$3.9M | ||
EBITDA | -$3.8M | ||
Net Working Capital | $78.2M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | 9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 02/27/2026 | ||
Earnings & Revenue